Tech Company Financing Transactions

PACT Pharma Funding Round

Vida Ventures and private investors joined a $75 million Series C venture round for PACT Pharma. The round was announced on 1/14/2020.

Transaction Overview

Company Name
Announced On
1/14/2020
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series C
Investors

Vida Ventures (Lead Investor) (Helen Kim)

Proceeds Purpose
PACT will use the Series C proceeds to expand the scope of its clinical plan to investigate NeoTCR-T cell products targeting multiple neoantigens for a spectrum of solid tumor types.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Corporate Dr.
San Francisco, CA 94080
USA
Phone
Undisclosed
Email Address
Overview
PACT Pharma is an independent, privately funded company recently launched by Arcus and scientific founders Jim Heath (Caltech), Toni Ribas (UCLA) and David Baltimore (Caltech). PACT's vision is to be the leader in creating, developing and commercializing cell-based therapies for the cure of cancer.
Profile
PACT Pharma LinkedIn Company Profile
Social Media
PACT Pharma Company Twitter Account
Company News
PACT Pharma News
Facebook
PACT Pharma on Facebook
YouTube
PACT Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alex Franzusoff
  Alex Franzusoff LinkedIn Profile  Alex Franzusoff Twitter Account  Alex Franzusoff News  Alex Franzusoff on Facebook
Chief Financial Officer
Uneek Mehra
  Uneek Mehra LinkedIn Profile  Uneek Mehra Twitter Account  Uneek Mehra News  Uneek Mehra on Facebook
Chief Technical Officer
Timothy Moore
  Timothy Moore LinkedIn Profile  Timothy Moore Twitter Account  Timothy Moore News  Timothy Moore on Facebook
Vice President
Stefanie Mandl
  Stefanie Mandl LinkedIn Profile  Stefanie Mandl Twitter Account  Stefanie Mandl News  Stefanie Mandl on Facebook
Vice President
Susan Whitehead
  Susan Whitehead LinkedIn Profile  Susan Whitehead Twitter Account  Susan Whitehead News  Susan Whitehead on Facebook
VP - Finance
Jeroen Grasman
  Jeroen Grasman LinkedIn Profile  Jeroen Grasman Twitter Account  Jeroen Grasman News  Jeroen Grasman on Facebook
VP - General Counsel
Atulya Agarwal
  Atulya Agarwal LinkedIn Profile  Atulya Agarwal Twitter Account  Atulya Agarwal News  Atulya Agarwal on Facebook
VP - Human Resources
Maria Simon
  Maria Simon LinkedIn Profile  Maria Simon Twitter Account  Maria Simon News  Maria Simon on Facebook
VP - Manufacturing
Gregory Yedinak
  Gregory Yedinak LinkedIn Profile  Gregory Yedinak Twitter Account  Gregory Yedinak News  Gregory Yedinak on Facebook
VP - Regulatory Affairs
Will White
  Will White LinkedIn Profile  Will White Twitter Account  Will White News  Will White on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/14/2020: Tyra Biosciences venture capital transaction
Next: 1/15/2020: Nicoya Lifesciences venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on every notable VC transaction. All VC database entries reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary